Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis

Shamliyan Tatyana A.; Dospinescu Paula

首页> 外文期刊>Clinical therapeutics >Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis

【24h】

Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis

机译：辅助生物反应改性剂的临床反应的额外改进，以中度至重度全身性狼疮红斑狼疮，尽管免疫抑制剂：系统审查和荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: The role of biologic disease-modifying drugs in patients with systemic lupus erythematosus (SLE) remains controversial.

机译：目的：生物疾病 - 改性药物在系统性狼疮患者中的作用仍然存在争议。

著录项

来源
《Clinical therapeutics》 |2017年第7期|共28页
作者
Shamliyan Tatyana A.; Dospinescu Paula;
展开▼
作者单位

Elsevier 1600 John Fitzgerald Kennedy Blvd Philadelphia PA 19103 USA;

NHS Grampian Dept Rheumatol Aberdeen Scotland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
systemic lupus erythematosus; belimumab; rituximab; abatacept; rigerimod; blisibimod;

机译：systemic lupus erythematosus;belimumab;rituximab;abatacept;Rigerimod;Blisibimod;

相似文献

外文文献
中文文献
专利

1. Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis [J] . Shamliyan Tatyana A., Dospinescu Paula Clinical therapeutics . 2017,第7期

机译：辅助生物反应改性剂的临床反应的额外改进，以中度至重度全身性狼疮红斑狼疮，尽管免疫抑制剂：系统审查和荟萃分析
2. Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus [J] . Shereen Oon, Molla Huq, Timothy Godfrey, Seminars in Arthritis and Rheumatism . 2018,第2期

机译：系统综述，以及类固醇味道效果的荟萃分析，对随机的，安慰剂控制第3阶段的生物学剂进行全身狼疮红斑狼疮
3. Response rate of systemic lupus erythematosus in trials assessing biologic agents: a meta-analysis [J] . Fundamental & clinical pharmacology. . 2019,第S1期

机译：在评估生物药物的试验中系统性红斑狼疮的反应率：META分析
4. Triptolide regulates immune response network against systemic lupus erythematosus [C] . Guang Zheng, Zhibin Wang, Chengqiang Li, IEEE International Conference on Bioinformatics and Biomedicine . 2016

机译：雷公藤甲素调节针对系统性红斑狼疮的免疫反应网络
5. Acquired Low Immunoglobulin Levels and Risk of Clinically Relevant Infection in Adult Patients with Systemic Lupus Erythematosus Cohort Study [D] . Almaghlouth, Ibrahim Ali S. 2019

机译：在成人狼疮患者中获得低免疫球蛋白水平和临床相关感染的风险红斑狼疮队列队列研究
6. Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis [O] . Evelien Bergrath, Robert A. Gerber, David Gruben, 2017

机译：对非生物DMARD反应不足的中度至重度类风湿关节炎患者使用Tofacitinib与生物疗法的比较：系统文献综述和网络荟萃分析
7. Comparison of structural magnetic resonance imaging findings between neuropsychiatric systemic lupus erythematosus and systemic lupus erythematosus patients: A systematic review and meta-analysis [O] . Amin Omed, Kaul Arvind, Smith Toby O, 2017

机译：神经精神性系统性红斑狼疮与系统性红斑狼疮患者的结构磁共振成像结果比较：系统评价和荟萃分析

Additional Improvements in Clinical Response From Adjuvant Biologic Response Modifiers in Adults With Moderate to Severe Systemic Lupus Erythematosus Despite Immunosuppressive Agents: A Systematic Review and Meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅